J. B. Chemicals & Pharmaceuticals Limited
JBCHEPHARM
Rang in aandelen
#3877
J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai,... J. B. Chemicals & Pharmaceuticals Limited, an enterprise founded in Mumbai, India, in 1976, specializes in the development, production, and global distribution of diverse pharmaceutical formulations, herbal remedies, and active pharmaceutical ingredients. Among its prominent product offerings are Cilnidipine, Ranitidine, and Metronidazole. Beyond its own brands, the company extends comprehensive contract manufacturing services, covering an extensive spectrum of dosage forms such as tablets, various lozenge types, injectables, gels, creams, ointments, liquid herbal syrups, and capsules. The firm further contributes to diagnostic medicine by supplying contrast agents for advanced imaging techniques like X-ray, MRI, and ultrasound. Its therapeutic expertise encompasses a broad range of medical fields, including gastroenterology, hypertension, diabetes, dermatology, nephrology, wound care, anti-infectives, and pharmacovigilance.
Aandeelprijs
$26.58
Laatst gesynchroniseerd: 2026-07-23
Marktkapitalisatie
$4.24B
Verandering (1 dag)
0.00%
Verandering (1 jaar)
38.14%
Land
IN
Handel J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
Categorie
Healthcare
EPS voor J. B. Chemicals & Pharmaceuticals Limited (JBCHEPHARM)
EPS per March 2026 TTM: $0.50
Volgens de laatste financiële rapporten en de aandelenkoers van J. B. Chemicals & Pharmaceuticals Limited is de huidige EPS van het bedrijf (TTM) $0.50. Eind 2024 had het bedrijf een EPS van $0.43, een stijging ten opzichte van de EPS van 2023 die $0.32 bedroeg.
EPS-geschiedenis van J. B. Chemicals & Pharmaceuticals Limited van 2005 tot 2026
EPS aan het einde van elk jaar
| Jaar | EPS | Wijzigen |
|---|---|---|
| 2026 (TTM) | $0.50 | -0.14% |
| 2025 | $0.50 | 16.04% |
| 2024 | $0.43 | 32.62% |
| 2023 | $0.32 | -1.80% |
| 2022 | $0.33 | -17.05% |
| 2021 | $0.40 | -13.65% |
| 2020 | $0.46 | 35.25% |
| 2019 | $0.34 | 33.94% |
| 2018 | $0.25 | -24.36% |
| 2017 | $0.33 | 15.70% |
| 2016 | $0.29 | 52.45% |
| 2015 | $0.19 | 56.65% |
| 2014 | $0.12 | -29.84% |
| 2013 | $0.17 | -89.07% |
| 2012 | $1.58 | 326.74% |
| 2011 | $0.37 | 18.09% |
| 2010 | $0.31 | 421.63% |
| 2009 | $0.06 | -55.22% |
| 2008 | $0.13 | -21.29% |
| 2007 | $0.17 | -13.10% |
| 2006 | $0.20 | 17.98% |
| 2005 | $0.17 | 0.00% |
EPS van vergelijkbare bedrijven of concurrenten
| Bedrijf | EPS | EPS-verschil | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | 11.42% |
IN
|
